Author:
Benson John D.,Chen Ying-Nan P.,Cornell-Kennon Susan A.,Dorsch Marion,Kim Sunkyu,Leszczyniecka Magdalena,Sellers William R.,Lengauer Christoph
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Deininger, M., Buchdunger, E. & Druker, B. J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 1, 2640–2653 (2005).
2. Emens, L. A. Trastuzumab: targeted therapy for the management of HER-2/neu-overexpressing metastatic breast cancer. Am. J. Ther. 12, 243–253 (2005).
3. Weinstein, I. Addiction to oncogenes: the Achilles Heel of Cancer. Science 297, 63–65 (2002).
4. Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W. & Friend, S. H. Integrating genetic approaches into the discovery of anticancer drugs. Science 278, 1064–1068 (1997).
5. Kaelin, W. J. Jr. The concept of synthetic lethality in the context of anticancer therapy. Nature Rev. Cancer 5, 689–698 (2005).
Cited by
133 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献